Palantir’s UK boss says the company has “no interest” in actual data, likening the company to Microsoft.
Amazon’s new Bio Discovery tool can design and run experiments for antibody research and drug synthesis.
All extensions seem to have been made by a single actor, possibly of Russian origin.
Geopolitics drives Europe toward tech control, yet costs, complexity, and entrenched providers hinder meaningful autonomy.
…
Most enterprises think a prompt is enough to keep their AI agents in check. It is not, and the gap between prompt-level instructions and platform-level governance is where things go wrong.
…
Why seamless, platform-agnostic meeting rooms are the key to frictionless hybrid work in 2026.
As Mythos steals the limelight, OpenAI is releasing GPT-5.4-Cyber and is teasing even better models down the line.
Backups are no longer enough as evolving threats undermine traditional cyber resilience strategies.
Cloud is growing fast but security is falling behind. Here’s why it matters.
DVSA explores remote theory testing and digital systems while maintaining strict test centre requirements amid ongoing backlog and fraud concerns.
…